Advances in Clinical Chemistry
- 1st Edition, Volume 134 - October 1, 2026
- Latest edition
- Editor: Gregory S. Makowski
- Language: English
Advances in Clinical Chemistry, Volume 134 in this ongoing series, examines physiologic and pathophysiologic biochemistry and impacts on Clinical Chemistry testing and design… Read more
Description
Description
As these evolving technologies and analytic strategies have become increasing relevant given the healthcare and socioeconomic impact worldwide, this book provides an essential reference.
Key features
Key features
- Covers the Omics of heart failure and the use of AI to refine personalized medicine and risk stratification
- Explores MicroRNAs as diagnostic and prognostic biomarkers in CVD
- Includes strategies in antidoping detection of pseudo-endogenous drugs
Readership
Readership
Table of contents
Table of contents
1. Biomarkers in Heart Failure
Alberto Aimo
2. RNA biomarkers in antidoping
Olivier Salamin
3. Cardiovascular disease and miRNA
Md Sayed Ali Sheikh
4. Chronic low-grade inflammation in vegetarians and vegans: biomarker evidence and methodological considerations
Goran Gajski
5. Advances in microfluidic extracellular vesicle technology
Sebastian Schwaminger
6. Biomarkers for Assessing Magnesium Status
Lusliany J Rondón
Product details
Product details
- Edition: 1
- Latest edition
- Volume: 134
- Published: October 1, 2026
- Language: English
About the editor
About the editor
GM
Gregory S. Makowski
Dr Gregory S Makowski is a board-certified clinical chemist and fellow of the National Academy of Clinical Biochemistry. Following receipt of his PhD in Biochemistry from the University of Connecticut Storrs, he pursued post-doctoral studies at the University of Connecticut School of Medicine in Farmington that culminated in joint appointments in the School of Medicine and the Department of Laboratory Medicine at John Dempsey Hospital. He has numerous clinical and basic science publications and serves on various scientific and editorial boards. He is actively engaged in the training of Pathology residents and fellows in the Department of Pathology and Laboratory Medicine at Hartford Hospital. He currently serves as Vice President Clinical Laboratory Services Hartford HealthCare in Connecticut.